{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/cg500302h.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": "error", "content": "<p>Captopril\nis an antihypertension drug, it has side effects of vertigo,\nheadache, and functional gastrointestinal disorders due to its overhigh\nplasma concentration. In addition, captopril undergoes oxidation at\nits thiol to yield captopril disulfide. In order to reduce its release\nrate and increase its oxidation stability, coordination polymer of\ncaptopril with zinc ion was prepared and its structure was determined\nby single crystal X-ray diffraction. The results of solubility measurements\nindicate that the apparent solubility and intrinsic dissolution rate\nof captopril can be dramatically decreased after the formation of\ncoordination polymer. Pharmacokinetic studies in rats reveal that\nthe plasma concentration of captopril can be reduced by the formation\nof zinc coordination polymer, with maximum plasma concentration reduced\nfrom 2.53 \u03bcg/mL for captopril to 0.99 \u03bcg/mL for the zinc\ncoordination polymer. Moreover, the oxidation stability of captopril\nis simultaneously improved by the formation of zinc coordination polymer.</p>", "clean_text": "Captopril is an antihypertension drug, it has side effects of vertigo, headache, and functional gastrointestinal disorders due to its overhigh plasma concentration. In addition, captopril undergoes oxidation at its thiol to yield captopril disulfide. In order to reduce its release rate and increase its oxidation stability, coordination polymer of captopril with zinc ion was prepared and its structure was determined by single crystal X-ray diffraction. The results of solubility measurements indicate that the apparent solubility and intrinsic dissolution rate of captopril can be dramatically decreased after the formation of coordination polymer. Pharmacokinetic studies in rats reveal that the plasma concentration of captopril can be reduced by the formation of zinc coordination polymer, with maximum plasma concentration reduced from 2.53 \u03bcg/mL for captopril to 0.99 \u03bcg/mL for the zinc coordination polymer. Moreover, the oxidation stability of captopril is simultaneously improved by the formation of zinc coordination polymer.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 2, "type": "text", "classification": "error", "content": "<p>The overhigh plasma concentration of\ncaptopril can be efficiently\nreduced simply by the formation of a coordination polymer with Zn(II)\nion.</p><title>Introduction</title><p>Captopril\n(Cap, Scheme ), an angiotensin-converting-enzyme\ninhibitor, is used for treatment of hypertension and heart failure.\nAfter an oral administration of 50 mg, the plasma concentration of\nCap could reach the maximum of 600 \u03bcg/L. Compared\nto its therapeutic concentration (50 \u03bcg/L), the much higher <italic toggle=\"yes\">C</italic>\n<sub>max</sub> of Cap may result in side effects of vertigo,\nheadache, and functional gastrointestinal disorders. In addition, Cap undergoes oxidation at its thiol group\nto yield captopril disulfide (Di-Cap, Scheme ) in aqueous solution. Approaches to\nutilize cyclodextrin, layered double hydroxides, and polymer-mesoporous\nsilica to slow down the release rate of captopril have been reported. We consider that the overhigh maximum plasma concentration of Cap\ncould be reduced simply by the formation of coordination polymers\nof metal ions with Cap, as Cap contains three potential donor groups\n(thiol, carboxyl, and amide) which might act as a linker to form coordination\npolymers with metal ions. In contrast to the formation of salts, which\nare usually considered as an approach to increase the solubility of\na drug, as the drug becomes cation or anion after the formation of\na salt, the solubility of the drug can usually be decreased after\nthe formation of coordination polymers, as drug molecules are difficult\nto escape from the frameworks of coordination polymers. Moreover,\nthe oxidation at the thiol group of Cap may simultaneously be prohibited\nby the formation of coordination polymers, as the thiol group of Cap\ncan be coordinated to metal ions. To our knowledge, reducing the overhigh\nmaximum plasma concentration of a drug by the formation of coordination\npolymers has not been reported so far.</p>", "clean_text": "The overhigh plasma concentration of captopril can be efficiently reduced simply by the formation of a coordination polymer with Zn(II) ion.\n\nIntroduction\n\nCaptopril (Cap, Scheme ), an angiotensin-converting-enzyme inhibitor, is used for treatment of hypertension and heart failure. After an oral administration of 50 mg, the plasma concentration of Cap could reach the maximum of 600 \u03bcg/L. Compared to its therapeutic concentration (50 \u03bcg/L), the much higher C max of Cap may result in side effects of vertigo, headache, and functional gastrointestinal disorders. In addition, Cap undergoes oxidation at its thiol group to yield captopril disulfide (Di-Cap, Scheme ) in aqueous solution. Approaches to utilize cyclodextrin, layered double hydroxides, and polymer-mesoporous silica to slow down the release rate of captopril have been reported. We consider that the overhigh maximum plasma concentration of Cap could be reduced simply by the formation of coordination polymers of metal ions with Cap, as Cap contains three potential donor groups (thiol, carboxyl, and amide) which might act as a linker to form coordination polymers with metal ions. In contrast to the formation of salts, which are usually considered as an approach to increase the solubility of a drug, as the drug becomes cation or anion after the formation of a salt, the solubility of the drug can usually be decreased after the formation of coordination polymers, as drug molecules are difficult to escape from the frameworks of coordination polymers. Moreover, the oxidation at the thiol group of Cap may simultaneously be prohibited by the formation of coordination polymers, as the thiol group of Cap can be coordinated to metal ions. To our knowledge, reducing the overhigh maximum plasma concentration of a drug by the formation of coordination polymers has not been reported so far.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 3, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Structure of Captopril\n(Cap) and Captopril Disulfide (Di-Cap)</title>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0008.tif\"></graphic>\n</fig>", "clean_text": " 1  Structure of Captopril (Cap) and Captopril Disulfide (Di-Cap)   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>In the present work, zinc ion was chosen to interact with\nCap,\nas it is an essential element and plays important roles in many biological\nprocesses of human body, and zinc salts, such as zinc sulfate, zinc\nacetate, and zinc gluconate are included in the list of \u201cgenerally\nrecognized as safe\u201d (GRAS). The reaction of Zn(II) with Cap\ngave a coordination polymer of captopril-Zn (<bold>Cap-Zn</bold>)\nrather than a Cap-Zinc salt. The difference between Cap-Zinc salt\nand <bold>Cap-Zn</bold> coordination polymer is that only the carboxylic\ngroup of Cap is deprotonated in Cap-Zinc salt, while both carboxylic\nand thiol groups of Cap are deprotonated in <bold>Cap-Zn</bold> coordination\npolymer, in which Cap<sup>\u20132</sup> anions alternately connect\nZn(II) to form a neutral coordination polymer. Herein, we reported\nthe structure, stability, solubility, and pharmacokinetics of <bold>Cap-Zn</bold> coordination polymer.</p>", "clean_text": "In the present work, zinc ion was chosen to interact with Cap, as it is an essential element and plays important roles in many biological processes of human body, and zinc salts, such as zinc sulfate, zinc acetate, and zinc gluconate are included in the list of \"generally recognized as safe\" (GRAS). The reaction of Zn(II) with Cap gave a coordination polymer of captopril-Zn (Cap-Zn) rather than a Cap-Zinc salt. The difference between Cap-Zinc salt and Cap-Zn coordination polymer is that only the carboxylic group of Cap is deprotonated in Cap-Zinc salt, while both carboxylic and thiol groups of Cap are deprotonated in Cap-Zn coordination polymer, in which Cap-2 anions alternately connect Zn(II) to form a neutral coordination polymer. Herein, we reported the structure, stability, solubility, and pharmacokinetics of Cap-Zn coordination polymer.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<title>Experimental\nSection</title><title>Materials and General Methods</title><p>Captopril was purchased\nfrom Suizhou Hongqi Chemical Co., Ltd. All of the other chemicals\nand solvents were commercially available and used as received. Elemental\nanalyses (EA) were carried out by Elementar Vario EL elemental analyzer.\nThe infrared spectra (IR) were recorded in the 4000 to 400 cm<sup>\u20131</sup> region using KBr pellets and a Bruker EQUINOX 55\nspectrometer. Thermogravimetric analyses (TGA) were recorded on a\nNetzsch TG-209 instrument and platinum crucible in nitrogen atmosphere,\nwith a heating rate of 10 \u00b0C/min. Differential scanning calorimetry\n(DSC) was recorded on a Netzsch STA 409PC instrument and aluminum\nsample pans in nitrogen atmosphere, with a heating rate of 10 \u00b0C/min.\nX-ray powder diffraction (XRPD) patterns were obtained on a Bruker\nD2 PHASER with Cu K\u03b1 radiation (30 kV, 10 mA)</p>", "clean_text": "Experimental Section\n\nMaterials and General Methods\n\nCaptopril was purchased from Suizhou Hongqi Chemical Co., Ltd. All of the other chemicals and solvents were commercially available and used as received. Elemental analyses (EA) were carried out by Elementar Vario EL elemental analyzer. The infrared spectra (IR) were recorded in the 4000 to 400 cm-1 region using KBr pellets and a Bruker EQUINOX 55 spectrometer. Thermogravimetric analyses (TGA) were recorded on a Netzsch TG-209 instrument and platinum crucible in nitrogen atmosphere, with a heating rate of 10 \u00b0C/min. Differential scanning calorimetry (DSC) was recorded on a Netzsch STA 409PC instrument and aluminum sample pans in nitrogen atmosphere, with a heating rate of 10 \u00b0C/min. X-ray powder diffraction (XRPD) patterns were obtained on a Bruker D2 PHASER with Cu K\u03b1 radiation (30 kV, 10 mA)", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "text", "classification": ["synthesis condition"], "content": "<title>\n<bold>Cap-Zn</bold> Coordination Polymer</title><p>This compound\nwas prepared via the following two methods:</p><p>(i) A mixture of\ncaptopril (217 mg, 1 mmol) and ZnO (41 mg, 0.5 mmol) was added to\n3 mL of methanol and allowed to stir overnight at room temperature.\nThe suspension was filtered and the isolated solid was washed with\nmethanol and dried under vacuum. Yield: 128.0 mg, 91.4% based on ZnO.\nAnal. Calcd for ZnC<sub>9</sub>H<sub>13</sub>NO<sub>3</sub>S: C, 38.52;\nN, 4.99; H, 4.67%. Found: C, 38.97; N, 5.05; H, 4.83%.</p>", "clean_text": " Cap-Zn Coordination Polymer\n\nThis compound was prepared via the following two methods:\n\n(i) A mixture of captopril (217 mg, 1 mmol) and ZnO (41 mg, 0.5 mmol) was added to 3 mL of methanol and allowed to stir overnight at room temperature. The suspension was filtered and the isolated solid was washed with methanol and dried under vacuum. Yield: 128.0 mg, 91.4% based on ZnO. Anal. Calcd for ZnC9H13NO3S: C, 38.52; N, 4.99; H, 4.67%. Found: C, 38.97; N, 5.05; H, 4.83%.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 7, "type": "text", "classification": ["synthesis condition"], "content": "<p>(ii)\nTo 2 mL of aqueous ZnCl<sub>2</sub> (136 mg, 1 mmol) was added\na solution of water (3 mL) containing captopril (87 mg, 0.4 mmol)\nand NaOH (12 mg, 0.4 mmol). The resulting solution was stirred overnight\nand filtered. The isolated solid was washed with methanol and dried\nunder vacuum. Yield: 101.2 mg, 90.3% based on captopril.</p>", "clean_text": "(ii) To 2 mL of aqueous ZnCl2 (136 mg, 1 mmol) was added a solution of water (3 mL) containing captopril (87 mg, 0.4 mmol) and NaOH (12 mg, 0.4 mmol). The resulting solution was stirred overnight and filtered. The isolated solid was washed with methanol and dried under vacuum. Yield: 101.2 mg, 90.3% based on captopril.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<p>Single\ncrystal of <bold>Cap-Zn</bold> was obtained by layering\na methanol solution of captopril and NaOH with an aqueous solution\nof ZnCl<sub>2</sub>.</p><title>Single Crystal X-ray Diffraction</title><p>Diffraction data for <bold>Cap-Zn</bold> were collected using an\nAgilent Technologies Gemini\nA Ultra system. Data reduction and cell refinement were performed\nwith the program of CrysAlis PRO. The\nstructure was solved by the direct method using the SHELXS-97 programs and refined by the full-matrix least-squares\nmethod on <italic toggle=\"yes\">F</italic>\n<sup>2</sup>. All non-hydrogen atoms were\nrefined with anisotropic displacement parameters. All hydrogen atoms\nwere placed in calculated positions with fixed isotropic thermal parameters\nand included in the structure factor calculations in the final stage\nof full-matrix least-squares refinement (Table ).</p>", "clean_text": "Single crystal of Cap-Zn was obtained by layering a methanol solution of captopril and NaOH with an aqueous solution of ZnCl2.\n\nSingle Crystal X-ray Diffraction\n\nDiffraction data for Cap-Zn were collected using an Agilent Technologies Gemini A Ultra system. Data reduction and cell refinement were performed with the program of CrysAlis PRO. The structure was solved by the direct method using the SHELXS-97 programs and refined by the full-matrix least-squares method on F 2. All non-hydrogen atoms were refined with anisotropic displacement parameters. All hydrogen atoms were placed in calculated positions with fixed isotropic thermal parameters and included in the structure factor calculations in the final stage of full-matrix least-squares refinement (Table ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystallographic Data and Refinements\nfor <bold>Cap-Zn</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup align=\"left\" cols=\"2\">\n<oasis:colspec colname=\"col1\"></oasis:colspec>\n<oasis:colspec colname=\"col2\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>Cap-Zn</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>formula</oasis:entry>\n<oasis:entry>ZnC<sub>9</sub>H<sub>13</sub>NO<sub>3</sub>S</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>formula weight</oasis:entry>\n<oasis:entry>280.63</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal system</oasis:entry>\n<oasis:entry>tetragonal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>4<sub>1</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.5790(12)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.5790(12)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>12.110(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">V</italic> (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>1111.2(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">Z</italic>\n</oasis:entry>\n<oasis:entry>4</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">D</italic>\n<sub>c</sub> (g\u00b7cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.677</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">F</italic>(000)</oasis:entry>\n<oasis:entry>576</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal size (mm)</oasis:entry>\n<oasis:entry>0.08 \u00d7 0.05 \u00d7\n0.02</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>range of indices</oasis:entry>\n<oasis:entry>\u20138 \u2264 <italic toggle=\"yes\">h</italic> \u2264\n11</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\u201310 \u2264 <italic toggle=\"yes\">k</italic> \u2264\n9</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\u201314 \u2264 <italic toggle=\"yes\">l</italic> \u2264\n12</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>int</sub>\n</oasis:entry>\n<oasis:entry>0.0742</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF</oasis:entry>\n<oasis:entry>1.018</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub>[ <italic toggle=\"yes\">I</italic> &gt; 2\u03c3(<italic toggle=\"yes\">I</italic>)]<xref rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.0613</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub> [all\ndata]<xref rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.1589</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Flack parameter</oasis:entry>\n<oasis:entry>0.04(7)</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>\u03b1</label>\n<p>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = \u03a3\u2225F<sub>o</sub>| \u2013 |<italic toggle=\"yes\">F</italic>\n<sub>c</sub>\u2225/\u03a3|<italic toggle=\"yes\">F</italic>\n<sub>o</sub>|. <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = [\u03a3[<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2013 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/\u03a3<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup>)<sup>2</sup>]<sup>1/2</sup>, and <italic toggle=\"yes\">w</italic> = 1/[\u03c3<sup>2</sup>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>)<sup>2</sup> + (<italic toggle=\"yes\">aP</italic>)<sup>2</sup> + <italic toggle=\"yes\">bP</italic>], where <italic toggle=\"yes\">P</italic> = [(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup>) + 2<italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>]/3.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 10, "type": "text", "classification": ["else"], "content": "<title>Stability</title><p>Stability\nevaluation was carried out by slurry\nmethod. In these experiments, excess solids were stirred in deionized\nwater for 72 h at 40 \u00b0C. Then the solvent was removed under reduced\npressure, and the solids were dissolved in the mixture of 0.1 M HCl\naqueous solution and methanol (3:7) and analyzed by HPLC to detect\nthe residual of captopril. HPLC analysis was performed on a Shimadzu\n20A HPLC system, which was equipped with Inertsil ODS-3 (150 mm \u00d7\n4.6 mm I.D., 5 \u03bcm) column. The mobile phase consisted of a mixture\nof 0.05% H<sub>3</sub>PO<sub>4</sub> aqueous solution and acetonitrile\n(73:27, v/v) at a flow rate of 1.0 mL/min. The column was kept at\nroom temperature, and the effluents were monitored at 220 nm.</p>", "clean_text": "Stability\n\nStability evaluation was carried out by slurry method. In these experiments, excess solids were stirred in deionized water for 72 h at 40 \u00b0C. Then the solvent was removed under reduced pressure, and the solids were dissolved in the mixture of 0.1 M HCl aqueous solution and methanol (3:7) and analyzed by HPLC to detect the residual of captopril. HPLC analysis was performed on a Shimadzu 20A HPLC system, which was equipped with Inertsil ODS-3 (150 mm \u00d7 4.6 mm I.D., 5 \u03bcm) column. The mobile phase consisted of a mixture of 0.05% H3PO4 aqueous solution and acetonitrile (73:27, v/v) at a flow rate of 1.0 mL/min. The column was kept at room temperature, and the effluents were monitored at 220 nm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 11, "type": "text", "classification": ["else"], "content": "<title>Powder\nDissolution Experiments</title><p>All the solids were\nmilled to powders and sieved using standard mesh sieves to provide\nsamples with the particle size ranges of 75\u2013150 \u03bcm. In\na typical experiment, a flask containing 300\u20131500 mg of powder\nwas added to 5 mL of Tris-HCl buffer or 0.1 M HCl aqueous solution,\nand the resulting suspension was stirred at 37 \u00b0C and 200 rpm.\nAt each time interval, an aliquot of the slurry was withdrawn from\nthe flask, followed by adding an equal volume of fresh medium to the\nsuspension and filtered through a 0.22 \u03bcm nylon filter. After\nappropriate dilutions, the solutions were injected into the HPLC system\nfor analysis.</p>", "clean_text": "Powder Dissolution Experiments\n\nAll the solids were milled to powders and sieved using standard mesh sieves to provide samples with the particle size ranges of 75-150 \u03bcm. In a typical experiment, a flask containing 300-1500 mg of powder was added to 5 mL of Tris-HCl buffer or 0.1 M HCl aqueous solution, and the resulting suspension was stirred at 37 \u00b0C and 200 rpm. At each time interval, an aliquot of the slurry was withdrawn from the flask, followed by adding an equal volume of fresh medium to the suspension and filtered through a 0.22 \u03bcm nylon filter. After appropriate dilutions, the solutions were injected into the HPLC system for analysis.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<p>Concentrations of Cap and <bold>Cap-Zn</bold> in\nTris-HCl buffer (pH = 6.8) and 0.1 M HCl aqueous solution (pH = 1)\nwere determined by HPLC. HPLC analysis was performed on a Shimadzu\n20A HPLC system, which was equipped with a Inertsil ODS-3 (150 mm\n\u00d7 4.6 mm I.D., 5 \u03bcm) column. The mobile phase consisted\nof a mixture of 0.01 M NaH<sub>2</sub>PO<sub>4</sub> aqueous solution\n(pH 3; adjusted with phosphoric acid) and methanol (65:35, v/v), at\na flow rate of 1.0 mL/min. The column was kept at room temperature,\nand the effluents were monitored at 220 nm.</p>", "clean_text": "Concentrations of Cap and Cap-Zn in Tris-HCl buffer (pH = 6.8) and 0.1 M HCl aqueous solution (pH = 1) were determined by HPLC. HPLC analysis was performed on a Shimadzu 20A HPLC system, which was equipped with a Inertsil ODS-3 (150 mm \u00d7 4.6 mm I.D., 5 \u03bcm) column. The mobile phase consisted of a mixture of 0.01 M NaH2PO4 aqueous solution (pH 3; adjusted with phosphoric acid) and methanol (65:35, v/v), at a flow rate of 1.0 mL/min. The column was kept at room temperature, and the effluents were monitored at 220 nm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 13, "type": "text", "classification": ["else"], "content": "<title>Intrinsic Dissolution Rate</title><p>The intrinsic dissolution\nrate (IDR) experiments of solid materials were carried out on a ZQY-2\nDissolution Tester (Shanghai Huanghai Yaojian instrument distribution\nCo., Ltd.). One hundred and fifty milligrams of each solid was compressed\nin a hydraulic press at 1 ton for 5 s in a die of a 5 mm diameter\ndisk. The disk was coated using paraffin wax, leaving only the surface\nunder investigation free for dissolution. Then, the disk was dipped\ninto 150 mL of 0.1 M HCl aqueous solution at 37 \u00b0C, with the\npaddle rotating at 100 rpm. At each time interval, 2 mL of the dissolution\nmedium was withdrawn and replaced by an equal volume of fresh medium\nto maintain a constant volume. After being filtered through 0.22 \u03bcm\nnylon filters, solutions were injected into the HPLC system for analysis.</p>", "clean_text": "Intrinsic Dissolution Rate\n\nThe intrinsic dissolution rate (IDR) experiments of solid materials were carried out on a ZQY-2 Dissolution Tester (Shanghai Huanghai Yaojian instrument distribution Co., Ltd.). One hundred and fifty milligrams of each solid was compressed in a hydraulic press at 1 ton for 5 s in a die of a 5 mm diameter disk. The disk was coated using paraffin wax, leaving only the surface under investigation free for dissolution. Then, the disk was dipped into 150 mL of 0.1 M HCl aqueous solution at 37 \u00b0C, with the paddle rotating at 100 rpm. At each time interval, 2 mL of the dissolution medium was withdrawn and replaced by an equal volume of fresh medium to maintain a constant volume. After being filtered through 0.22 \u03bcm nylon filters, solutions were injected into the HPLC system for analysis.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 14, "type": "text", "classification": ["else"], "content": "<title>Pharmacokinetics in Rat Plasma</title><p>Male Sprague\u2013Dawley\nrats weighing 200 \u00b1 20 g for in vivo pharmacokinetics study were\npurchased from the animal research center of Sun Yat-sen University\n(Guangzhou, China) and housed in a temperature- and humidity-controlled\nroom with a 12 h light/dark cycle with free access to food and water.\nAll the animal experiments were carried out in accordance with institutional\nguidelines in compliance with regulations formulated by Sun Yat-sen\nUniversity. The experimental protocol was approved by the Institutional\nAnimal Care and Use Committee of Sun Yat-sen University.</p>", "clean_text": "Pharmacokinetics in Rat Plasma\n\nMale Sprague-Dawley rats weighing 200 \u00b1 20 g for in vivo pharmacokinetics study were purchased from the animal research center of Sun Yat-sen University (Guangzhou, China) and housed in a temperature- and humidity-controlled room with a 12 h light/dark cycle with free access to food and water. All the animal experiments were carried out in accordance with institutional guidelines in compliance with regulations formulated by Sun Yat-sen University. The experimental protocol was approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 15, "type": "text", "classification": "error", "content": "<p>Pharmacokinetics\nwas evaluated in five male Sprague\u2013Dawley rats (200 \u00b1\n20 g) per formulation, which were fasted for 12 h before drug administration.\nThe solid of Cap or <bold>Cap-Zn</bold> was added to 0.5% CMC-Na aqueous\nsolution (pH = 6.9) and then was orally administered at 20 mg/kg (the\nequivalent amount of free captopril) to rats, respectively. Blood\nsamples were extracted from retro-orbital sinus using a Pasteur pipet,\nat the following time intervals: 0, 5, 10, 15, 20, 25, 30, 40, 50,\n60, 90, 120, and 180 min after oral dosing, respectively. The plasma\nsamples were separated by centrifugation (5 min, 6000 rpm). The total\namount of captopril in plasma was determined by treating the plasma\nwith <italic toggle=\"yes\">p</italic>-bromophenacyl bromide (<italic toggle=\"yes\">p</italic>-BPB)\nto reduce the oxidized form of captopril (Di-Cap) and used <italic toggle=\"yes\">p</italic>-BPB as a chromophore to detect captopril.\n</p>", "clean_text": "Pharmacokinetics was evaluated in five male Sprague-Dawley rats (200 \u00b1 20 g) per formulation, which were fasted for 12 h before drug administration. The solid of Cap or Cap-Zn was added to 0.5% CMC-Na aqueous solution (pH = 6.9) and then was orally administered at 20 mg/kg (the equivalent amount of free captopril) to rats, respectively. Blood samples were extracted from retro-orbital sinus using a Pasteur pipet, at the following time intervals: 0, 5, 10, 15, 20, 25, 30, 40, 50, 60, 90, 120, and 180 min after oral dosing, respectively. The plasma samples were separated by centrifugation (5 min, 6000 rpm). The total amount of captopril in plasma was determined by treating the plasma with p-bromophenacyl bromide (p-BPB) to reduce the oxidized form of captopril (Di-Cap) and used p-BPB as a chromophore to detect captopril. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 16, "type": "text", "classification": ["else"], "content": "<p>To 200 \u03bcL of plasma was added 20 \u03bcL of 1 mg/mL <italic toggle=\"yes\">p</italic>-BPB acetonitrile solution. The mixture was vortex-mixed\nfor 5 min and allowed to stand in dark for 1 h. Then, to the mixture\nwas added 80 \u03bcL of 1 M HCl aqueous solution, and it extracted\nwith 800 \u03bcL of benzene-ethyl acetate (1:1, v/v). The organic\nlayer was evaporated to dryness under vacuum and reconstituted in\n50 \u03bcL of acetonitrile. A portion of 20 \u03bcL was injected\ninto the HPLC.</p>", "clean_text": "To 200 \u03bcL of plasma was added 20 \u03bcL of 1 mg/mL p-BPB acetonitrile solution. The mixture was vortex-mixed for 5 min and allowed to stand in dark for 1 h. Then, to the mixture was added 80 \u03bcL of 1 M HCl aqueous solution, and it extracted with 800 \u03bcL of benzene-ethyl acetate (1:1, v/v). The organic layer was evaporated to dryness under vacuum and reconstituted in 50 \u03bcL of acetonitrile. A portion of 20 \u03bcL was injected into the HPLC.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 17, "type": "text", "classification": ["else"], "content": "<p>HPLC analysis was performed on a Shimadzu 20A\nHPLC system, which\nwas equipped with a Inertsil ODS-3 (150 mm \u00d7 4.6 mm I.D., 5 \u03bcm)\ncolumn. The mobile phase consisted of a mixture of 0.5% acetic aqueous\nsolution and acetonitrile (55:45, v/v), at a flow rate of 1.0 mL/min.\nThe column was kept at room temperature, and the effluents were monitored\nat 260 nm. The plasma concentration\u2013time data were fitted using\nWinNonlin 5.0.1 software, and the pharmacokinetics parameters such\nas <italic toggle=\"yes\">t</italic>\n<sub>max</sub>, <italic toggle=\"yes\">C</italic>\n<sub>max</sub>, AUC, and MRT were obtained (Table ). All\nthe values were presented as mean \u00b1 SD for five rats. Statistically\nsignificant differences between two groups were evaluated by Student\u2019s <italic toggle=\"yes\">t</italic> test. A probability (<italic toggle=\"yes\">P</italic>) of less than\n0.05 is considered statistically significant.</p>", "clean_text": "HPLC analysis was performed on a Shimadzu 20A HPLC system, which was equipped with a Inertsil ODS-3 (150 mm \u00d7 4.6 mm I.D., 5 \u03bcm) column. The mobile phase consisted of a mixture of 0.5% acetic aqueous solution and acetonitrile (55:45, v/v), at a flow rate of 1.0 mL/min. The column was kept at room temperature, and the effluents were monitored at 260 nm. The plasma concentration-time data were fitted using WinNonlin 5.0.1 software, and the pharmacokinetics parameters such as t max, C max, AUC, and MRT were obtained (Table ). All the values were presented as mean \u00b1 SD for five rats. Statistically significant differences between two groups were evaluated by Student's t test. A probability (P) of less than 0.05 is considered statistically significant.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 18, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Mean Pharmacokinetic\nParameters for\nCap and <bold>Cap-Zn</bold> in Male Rat (<italic toggle=\"yes\">n</italic> = 5)<xref rid=\"t2fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup align=\"left\" cols=\"3\">\n<oasis:colspec colname=\"col1\"></oasis:colspec>\n<oasis:colspec colname=\"col2\"></oasis:colspec>\n<oasis:colspec char=\" \u00b1 \" colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">parameter</oasis:entry>\n<oasis:entry align=\"center\">Cap</oasis:entry>\n<oasis:entry align=\"center\">Cap-Zn</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">t</italic>\n<sub>max</sub> (min)</oasis:entry>\n<oasis:entry>10</oasis:entry>\n<oasis:entry>23 \u00b1 2.74<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">C</italic>\n<sub>max</sub> (\u03bcg/mL)</oasis:entry>\n<oasis:entry>2.53 \u00b1 0.41</oasis:entry>\n<oasis:entry>0.99 \u00b1 0.15<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>AUC<sub>0\u2011\u221e</sub> (\u03bcg\u00b7min/mL)</oasis:entry>\n<oasis:entry>58.74 \u00b1 5.54</oasis:entry>\n<oasis:entry>42.03\n\u00b1 11.33<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>MRT<sub>0\u2011\u221e</sub> (min)</oasis:entry>\n<oasis:entry>31.56 \u00b1 6.10</oasis:entry>\n<oasis:entry>43.64\n\u00b1 5.73<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Each value represents the mean \u00b1\nSD (<italic toggle=\"yes\">n</italic> = 5).</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>\n<italic toggle=\"yes\">P</italic> &lt; 0.05.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 19, "type": "text", "classification": ["else"], "content": "<title>Results and Discussion</title><title>Crystal Structure of <bold>Cap-Zn</bold>\n</title><p>The asymmetric\nunit of <bold>Cap-Zn</bold> contains one zinc cation and one captopril\nanion, in which both carboxyl and thiol groups of captopril are deprotonated\n(Figure a). The Zn(II) ion displays a tetrahedral\ngeometry by coordinating with two sulfur atoms and two carboxylate\noxygen atoms from four individual captopril anions. In <bold>Cap-Zn</bold>, the Zn(II) ions are alternately connected by captopril anions to\nform a right-handed helical chain along the <italic toggle=\"yes\">c</italic> axis\n(Figure b). Each helix contains four Zn(II)\nand four captopril anions, with a pitch of 12.11 \u00c5. Each right-handed\nhelical chain connects with four adjacent right-handed helical chains\nthrough Zn\u2013S and Zn\u2013O1 coordination interactions, resulting\nin a 3D homochiral coordination polymer of <bold>Cap-Zn</bold> (Figure c,d).</p>", "clean_text": "Results and Discussion\n\nCrystal Structure of Cap-Zn \n\nThe asymmetric unit of Cap-Zn contains one zinc cation and one captopril anion, in which both carboxyl and thiol groups of captopril are deprotonated (Figure a). The Zn(II) ion displays a tetrahedral geometry by coordinating with two sulfur atoms and two carboxylate oxygen atoms from four individual captopril anions. In Cap-Zn, the Zn(II) ions are alternately connected by captopril anions to form a right-handed helical chain along the c axis (Figure b). Each helix contains four Zn(II) and four captopril anions, with a pitch of 12.11 \u00c5. Each right-handed helical chain connects with four adjacent right-handed helical chains through Zn-S and Zn-O1 coordination interactions, resulting in a 3D homochiral coordination polymer of Cap-Zn (Figure c,d).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 20, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>(a) Coordination environments of Zn and coordination\nmode of Cap.\n(b) Side view of 1D right-handed helical chain along the <italic toggle=\"yes\">c</italic> axis. (c) Coordination bonds between the adjacent helical chains.\n(d) Three-dimensional structure of <bold>Cap-Zn</bold> (view from\nthe <italic toggle=\"yes\">c</italic> axis).</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0002.tif\"></graphic>\n</fig>", "clean_text": " 1  (a) Coordination environments of Zn and coordination mode of Cap. (b) Side view of 1D right-handed helical chain along the c axis. (c) Coordination bonds between the adjacent helical chains. (d) Three-dimensional structure of Cap-Zn (view from the c axis).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 21, "type": "text", "classification": ["property"], "content": "<title>Stability</title><p>The thermal behaviors of <bold>Cap-Zn</bold> were\ninvestigated by DSC and TGA, and the results are presented\nin Figure . From the TG curve it can be found\nthat no weight loss belonging to residual solvent was detected. <bold>Cap-Zn</bold> can be stable up to 250 \u00b0C and then begins to\ndecompose upon further heating. Compared to the decomposition temperature\nof Cap at 170 \u00b0C, <bold>Cap-Zn</bold> shows the enhanced thermal\nstability (250 \u00b0C).</p>", "clean_text": "Stability\n\nThe thermal behaviors of Cap-Zn were investigated by DSC and TGA, and the results are presented in Figure . From the TG curve it can be found that no weight loss belonging to residual solvent was detected. Cap-Zn can be stable up to 250 \u00b0C and then begins to decompose upon further heating. Compared to the decomposition temperature of Cap at 170 \u00b0C, Cap-Zn shows the enhanced thermal stability (250 \u00b0C).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>DSC and TG curves for <bold>Cap-Zn</bold> (red)\nand Cap (blue).</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0003.tif\"></graphic>\n</fig>", "clean_text": " 2  DSC and TG curves for Cap-Zn (red) and Cap (blue).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "text", "classification": "error", "content": "<p>Oxidation stability was\nevaluated by slurry method. After slurrying\nthe solids in deionized water at 40 \u00b0C for 3 days, the residuals\nof Cap are 90 and 98% for Cap and <bold>Cap-Zn</bold>, respectively,\ndemonstrating the oxidation stability of Cap is enhanced after the\nformation of <bold>Cap-Zn</bold> coordination polymer. From the crystal\nstructure of <bold>Cap-Zn</bold> it can be found that thiol is coordinated\nwith zinc ion, which results in the improved stability of <bold>Cap-Zn</bold>.</p>", "clean_text": "Oxidation stability was evaluated by slurry method. After slurrying the solids in deionized water at 40 \u00b0C for 3 days, the residuals of Cap are 90 and 98% for Cap and Cap-Zn, respectively, demonstrating the oxidation stability of Cap is enhanced after the formation of Cap-Zn coordination polymer. From the crystal structure of Cap-Zn it can be found that thiol is coordinated with zinc ion, which results in the improved stability of Cap-Zn.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 24, "type": "text", "classification": "error", "content": "<title>Powder Dissolution</title><p>Powder dissolution profiles for\nCap and <bold>Cap-Zn</bold> are shown in Figure . From Figure  it can be found that after\nformation of <bold>Cap-Zn</bold> coordination polymer, the apparent\nsolubility of Cap in the Tris-HCl buffer solution (pH = 6.8) was dramatically\ndecreased from 140 mg/mL for the free Cap to 0.3 mg/mL for the <bold>Cap-Zn</bold> coordination polymer (Figure a) . In 0.1 M HCl aqueous solution, <bold>Cap-Zn</bold> displays\ndifferent dissolution behavior; the apparent solubility value of <bold>Cap-Zn</bold> is one-seventh as much as that of Cap (Figure b). After the dissolution experiments, the undissolved\nsolids were filtered and dried under vacuum. The result of XRPD analyses\nindicates that <bold>Cap-Zn</bold> solid does not change during the\nexperiment (Figure ), while the pH value of\nthe solution changed from 1 to 3 after the experiment, which is attributed\nto the protonation of dissolved captopril anion, and this was confirmed\nby the ESI-MS measurement (Figure S1, ).</p>", "clean_text": "Powder Dissolution\n\nPowder dissolution profiles for Cap and Cap-Zn are shown in Figure . From Figure  it can be found that after formation of Cap-Zn coordination polymer, the apparent solubility of Cap in the Tris-HCl buffer solution (pH = 6.8) was dramatically decreased from 140 mg/mL for the free Cap to 0.3 mg/mL for the Cap-Zn coordination polymer (Figure a) . In 0.1 M HCl aqueous solution, Cap-Zn displays different dissolution behavior; the apparent solubility value of Cap-Zn is one-seventh as much as that of Cap (Figure b). After the dissolution experiments, the undissolved solids were filtered and dried under vacuum. The result of XRPD analyses indicates that Cap-Zn solid does not change during the experiment (Figure ), while the pH value of the solution changed from 1 to 3 after the experiment, which is attributed to the protonation of dissolved captopril anion, and this was confirmed by the ESI-MS measurement (Figure S1, ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Powder dissolution profiles for Cap and <bold>Cap-Zn</bold> in\nTris-HCl buffer of pH 6.8 (a) and 0.1 M HCl aqueous solution (b).</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0004.tif\"></graphic>\n</fig>", "clean_text": " 3  Powder dissolution profiles for Cap and Cap-Zn in Tris-HCl buffer of pH 6.8 (a) and 0.1 M HCl aqueous solution (b).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>XRPD patterns for <bold>Cap-Zn</bold> after\npowder dissolution\nexperiment in Tris-HCl buffer of pH 6.8 (blue) and 0.1 M HCl aqueous\nsolution (red) (black, simulated XRPD pattern from the single-crystal\ndiffraction of <bold>Cap-Zn</bold>).</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0005.tif\"></graphic>\n</fig>", "clean_text": " 4  XRPD patterns for Cap-Zn after powder dissolution experiment in Tris-HCl buffer of pH 6.8 (blue) and 0.1 M HCl aqueous solution (red) (black, simulated XRPD pattern from the single-crystal diffraction of Cap-Zn).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "text", "classification": ["else"], "content": "<title>Intrinsic Dissolution Rate</title><p>IDR is a key physicochemical\nparameter commonly used to assess the dissolution-rate controlled\nabsorption of a new compound. Owing to its kinetic nature, IDR assumes\na better correlation with in vivo drug dissolution dynamics than solubility. To quantitatively evaluate the impact of the\nsolid-state modification on the dissolution behavior, as well as to\nestimate the clinical potential of <bold>Cap-Zn</bold>, studies of\nintrinsic dissolution rate were carried out in 0.1 M HCl aqueous solution\nand Tris-HCl buffer (pH = 6.8).</p>", "clean_text": "Intrinsic Dissolution Rate\n\nIDR is a key physicochemical parameter commonly used to assess the dissolution-rate controlled absorption of a new compound. Owing to its kinetic nature, IDR assumes a better correlation with in vivo drug dissolution dynamics than solubility. To quantitatively evaluate the impact of the solid-state modification on the dissolution behavior, as well as to estimate the clinical potential of Cap-Zn, studies of intrinsic dissolution rate were carried out in 0.1 M HCl aqueous solution and Tris-HCl buffer (pH = 6.8).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 28, "type": "text", "classification": "error", "content": "<p>As the concentration of <bold>Cap-Zn</bold> in Tris-HCl buffer is too low to be detected by HPLC\nduring the IDR experiment, the discussion is focused on the results\nin 0.1 M HCl aqueous solution. The intrinsic dissolution profiles\nwithin the first hour of the studied systems are shown in Figure . The calculated <italic toggle=\"yes\">R</italic>\n<sup>2</sup> for\nCap shows excellent linearity over the entire time interval, while <italic toggle=\"yes\">R</italic>\n<sup>2</sup> is relatively low (0.98) for <bold>Cap-Zn</bold>, which can be ascribed to the disproportionation of <bold>Cap-Zn</bold> in 0.1 M HCl aqueous solution. The IDR curve for <bold>Cap-Zn</bold> is a result of two processes, namely, the dissolution accompanied\nby disproportionation, so it does not show a perfect linearity. From\nthe result of the IDR experiments it can be found that <bold>Cap-Zn</bold> shows a slower dissolution rate than Cap, which coincides with the\nresult of the powder dissolution experiments. <bold>Cap-Zn</bold> displays\nthe reduced solubility because Cap and zinc ion are connected by coordination\nbonds, which are stronger than hydrogen bonds. Since solubility and\nbioavailability are often related, it is supposed that <bold>Cap-Zn</bold> may reduce the overhigh plasma concentration peak.</p>", "clean_text": "As the concentration of Cap-Zn in Tris-HCl buffer is too low to be detected by HPLC during the IDR experiment, the discussion is focused on the results in 0.1 M HCl aqueous solution. The intrinsic dissolution profiles within the first hour of the studied systems are shown in Figure . The calculated R 2 for Cap shows excellent linearity over the entire time interval, while R 2 is relatively low (0.98) for Cap-Zn, which can be ascribed to the disproportionation of Cap-Zn in 0.1 M HCl aqueous solution. The IDR curve for Cap-Zn is a result of two processes, namely, the dissolution accompanied by disproportionation, so it does not show a perfect linearity. From the result of the IDR experiments it can be found that Cap-Zn shows a slower dissolution rate than Cap, which coincides with the result of the powder dissolution experiments. Cap-Zn displays the reduced solubility because Cap and zinc ion are connected by coordination bonds, which are stronger than hydrogen bonds. Since solubility and bioavailability are often related, it is supposed that Cap-Zn may reduce the overhigh plasma concentration peak.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 29, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>IDR profiles for Cap\nand <bold>Cap-Zn</bold> in 0.1 M HCl aqueous\nsolution.</p>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0006.tif\"></graphic>\n</fig>", "clean_text": " 5  IDR profiles for Cap and Cap-Zn in 0.1 M HCl aqueous solution.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 30, "type": "text", "classification": "error", "content": "<title>Pharmacokinetics in Rat\nPlasma</title><p>The plasma concentration\u2013time\nprofiles of Cap and <bold>Cap-Zn</bold> are shown in Figure . The curves of two formulations were both fitted\nin a noncompartmental model. The mean pharmacokinetic parameters are\nsummarized in Table . From Table , it can be found that the pharmacokinetic parameters\nof <bold>Cap-Zn</bold> are statistically different from those of Cap.\nThe low apparent solubility and slower dissolution rate of <bold>Cap-Zn</bold> result in lower <italic toggle=\"yes\">C</italic>\n<sub>max</sub> and longer <italic toggle=\"yes\">t</italic>\n<sub>max</sub>, which change from 2.53 \u03bcg/mL and\n10 min for Cap to 0.99 \u03bcg/mL and 23 min for <bold>Cap-Zn</bold>. We believe that <bold>Cap-Zn</bold> was absorbed through a dissociated\nform rather than a complex molecule, as <bold>Cap-Zn</bold> can be\ntransformed to free Cap in 0.1 M HCl aqueous solution, as evidenced\nby the ESI-MS measurement (Figure S1, ). It can be expected that the lower <italic toggle=\"yes\">C</italic>\n<sub>max</sub> of <bold>Cap-Zn</bold> may reduce the side effects\nof captopril. Although <bold>Cap-Zn</bold> has a relatively lower\nAUC, its MRT is longer than that of Cap, which means the therapeutic\neffect of <bold>Cap-Zn</bold> may sustain for a longer period of time.</p>", "clean_text": "Pharmacokinetics in Rat Plasma\n\nThe plasma concentration-time profiles of Cap and Cap-Zn are shown in Figure . The curves of two formulations were both fitted in a noncompartmental model. The mean pharmacokinetic parameters are summarized in Table . From Table , it can be found that the pharmacokinetic parameters of Cap-Zn are statistically different from those of Cap. The low apparent solubility and slower dissolution rate of Cap-Zn result in lower C max and longer t max, which change from 2.53 \u03bcg/mL and 10 min for Cap to 0.99 \u03bcg/mL and 23 min for Cap-Zn. We believe that Cap-Zn was absorbed through a dissociated form rather than a complex molecule, as Cap-Zn can be transformed to free Cap in 0.1 M HCl aqueous solution, as evidenced by the ESI-MS measurement (Figure S1, ). It can be expected that the lower C max of Cap-Zn may reduce the side effects of captopril. Although Cap-Zn has a relatively lower AUC, its MRT is longer than that of Cap, which means the therapeutic effect of Cap-Zn may sustain for a longer period of time.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 31, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Plasma\nconcentration\u2013time profiles for Cap and <bold>Cap-Zn</bold> after oral administration. Each point represents the mean \u00b1\nSD (<italic toggle=\"yes\">n</italic> = 5).</p>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0007.tif\"></graphic>\n</fig>", "clean_text": " 6  Plasma concentration-time profiles for Cap and Cap-Zn after oral administration. Each point represents the mean \u00b1 SD (n = 5).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 32, "type": "text", "classification": "error", "content": "<title>Conclusions</title><p>A coordination polymer of captopril with\nzinc ion was synthesized,\nand its structure was determined by single crystal X-ray diffraction\nin which both thiol and carboxyl groups of captopril are deprotonated\nand coordinated with zinc ion to form a 1D coordination polymer of <bold>Cap-Zn</bold>. The oxidation stability of captopril is improved after\nthe formation of coordination polymer. The results of solubility and\nIDR experiments indicate that <bold>Cap-Zn</bold> shows a reduced\napparent solubility and dissolution rate compared to Cap. In 0.1 M\nHCl aqueous solution, <bold>Cap-Zn</bold> was disproportionate to\ncaptopril molecule during dissolution experiments. Pharmacokinetic\nresearch indicates that the maximum plasma concentration reduced from\n2.53 \u03bcg/mL for captopril to 0.99 \u03bcg/mL for <bold>Cap-Zn</bold>. The results presented herein provide a simple, efficient, and new\napproach to reduce the release rate and overhigh plasma concentration\nof a given drug.</p>", "clean_text": "Conclusions\n\nA coordination polymer of captopril with zinc ion was synthesized, and its structure was determined by single crystal X-ray diffraction in which both thiol and carboxyl groups of captopril are deprotonated and coordinated with zinc ion to form a 1D coordination polymer of Cap-Zn. The oxidation stability of captopril is improved after the formation of coordination polymer. The results of solubility and IDR experiments indicate that Cap-Zn shows a reduced apparent solubility and dissolution rate compared to Cap. In 0.1 M HCl aqueous solution, Cap-Zn was disproportionate to captopril molecule during dissolution experiments. Pharmacokinetic research indicates that the maximum plasma concentration reduced from 2.53 \u03bcg/mL for captopril to 0.99 \u03bcg/mL for Cap-Zn. The results presented herein provide a simple, efficient, and new approach to reduce the release rate and overhigh plasma concentration of a given drug.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 33, "type": "text", "classification": ["else"], "content": "<p>This work was\nfinancially supported by NSFC (grant no. 21101173, 91127002, and 21331007),\nNSF of Guangdong Province (S2012030006240), and Guangzhou Pearl River\nNew Star Fund Science and Technology Planning Project to J.-M.C. (2013J2200054).</p>", "clean_text": "This work was financially supported by NSFC (grant no. 21101173, 91127002, and 21331007), NSF of Guangdong Province (S2012030006240), and Guangzhou Pearl River New Star Fund Science and Technology Planning Project to J.-M.C. (2013J2200054).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 34, "type": "text", "classification": ["else"], "content": "<p>ESI-MS of <bold>Cap-Zn</bold> in 0.1 M HCl aqueous solution; XRPD patterns, IR spectrum for <bold>Cap-Zn</bold>, and HPLC for Cap and <bold>Cap-Zn</bold>. This material\nis available free of charge via the Internet at <uri xlink:href=\"http://pubs.acs.org\">http://pubs.acs.org</uri>.</p><p>The authors declare no\ncompeting financial interest.</p><title>References</title>", "clean_text": "ESI-MS of Cap-Zn in 0.1 M HCl aqueous solution; XRPD patterns, IR spectrum for Cap-Zn, and HPLC for Cap and Cap-Zn. This material is available free of charge via the Internet at http://pubs.acs.org.\n\nThe authors declare no competing financial interest.\n\nReferences", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": "6, 7", "type": "text", "classification": "synthesis condition", "content": "<title>\n<bold>Cap-Zn</bold> Coordination Polymer</title><p>This compound\nwas prepared via the following two methods:</p><p>(i) A mixture of\ncaptopril (217 mg, 1 mmol) and ZnO (41 mg, 0.5 mmol) was added to\n3 mL of methanol and allowed to stir overnight at room temperature.\nThe suspension was filtered and the isolated solid was washed with\nmethanol and dried under vacuum. Yield: 128.0 mg, 91.4% based on ZnO.\nAnal. Calcd for ZnC<sub>9</sub>H<sub>13</sub>NO<sub>3</sub>S: C, 38.52;\nN, 4.99; H, 4.67%. Found: C, 38.97; N, 5.05; H, 4.83%.</p><p>(ii)\nTo 2 mL of aqueous ZnCl<sub>2</sub> (136 mg, 1 mmol) was added\na solution of water (3 mL) containing captopril (87 mg, 0.4 mmol)\nand NaOH (12 mg, 0.4 mmol). The resulting solution was stirred overnight\nand filtered. The isolated solid was washed with methanol and dried\nunder vacuum. Yield: 101.2 mg, 90.3% based on captopril.</p>", "clean_text": " Cap-Zn Coordination Polymer\n\nThis compound was prepared via the following two methods:\n\n(i) A mixture of captopril (217 mg, 1 mmol) and ZnO (41 mg, 0.5 mmol) was added to 3 mL of methanol and allowed to stir overnight at room temperature. The suspension was filtered and the isolated solid was washed with methanol and dried under vacuum. Yield: 128.0 mg, 91.4% based on ZnO. Anal. Calcd for ZnC9H13NO3S: C, 38.52; N, 4.99; H, 4.67%. Found: C, 38.97; N, 5.05; H, 4.83%.\n\n(ii) To 2 mL of aqueous ZnCl2 (136 mg, 1 mmol) was added a solution of water (3 mL) containing captopril (87 mg, 0.4 mmol) and NaOH (12 mg, 0.4 mmol). The resulting solution was stirred overnight and filtered. The isolated solid was washed with methanol and dried under vacuum. Yield: 101.2 mg, 90.3% based on captopril.", "data": [[{"meta": {"name": "Cap-Zn Coordination Polymer", "symbol": "", "chemical formula": "ZnC9H13NO3S"}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "captopril", "amount": "217", "unit": "mg"}, {"name": "ZnO", "amount": "41", "unit": "mg"}], "solution": [{"name": "methanol", "amount": "3", "unit": "mL"}], "pressure": "", "temperature": "room temperature", "time": "overnight"}, {"synthesis method": "filtration", "time": "", "atmosphere": "", "pressure": ""}, {"synthesis method": "washing", "washing solution": "methanol", "amount": ""}, {"synthesis method": "drying", "pressure": "", "temperature": "", "atmosphere": "vacuum", "time": ""}], "yield": "91.4%"}, {"meta": {"name": "Cap-Zn Coordination Polymer", "symbol": "", "chemical formula": "ZnC9H13NO3S"}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "captopril", "amount": "87", "unit": "mg"}, {"name": "ZnCl2", "amount": "136", "unit": "mg"}, {"name": "NaOH", "amount": "12", "unit": "mg"}], "solution": [{"name": "water", "amount": "2", "unit": "mL"}, {"name": "water", "amount": "3", "unit": "mL"}], "pressure": "", "temperature": "room temperature", "time": "overnight"}, {"synthesis method": "filtration", "time": "", "atmosphere": "", "pressure": ""}, {"synthesis method": "washing", "washing solution": "methanol", "amount": ""}, {"synthesis method": "drying", "pressure": "", "temperature": "", "atmosphere": "vacuum", "time": ""}], "yield": "90.3%"}]], "include_properties": ["drying", "filtration", "washing", "chemical_synthesis"], "intermediate_step": {"text-synthesis-type": "['chemical_synthesis', 'filtration', 'washing', 'drying']", "text-synthesis-struct": "```JSON\n[{\"meta\":{\"name\":\"Cap-Zn Coordination Polymer\", \"symbol\":\"\", \"chemical formula\":\"ZnC9H13NO3S\"}, \"processes\":[{\"synthesis method\":\"chemical synthesis\", \"precursor\":[{\"name\":\"captopril\", \"amount\":\"217\", \"unit\":\"mg\"}, {\"name\":\"ZnO\", \"amount\":\"41\", \"unit\":\"mg\"}], \"solution\":[{\"name\":\"methanol\", \"amount\":\"3\", \"unit\":\"mL\"}], \"pressure\":\"\", \"temperature\":\"room temperature\", \"time\":\"overnight\"}, {\"synthesis method\":\"filtration\", \"time\":\"\", \"atmosphere\":\"\", \"pressure\":\"\"}, {\"synthesis method\":\"washing\", \"washing solution\":\"methanol\", \"amount\":\"\"}, {\"synthesis method\":\"drying\", \"pressure\":\"\", \"temperature\":\"\", \"atmosphere\":\"vacuum\", \"time\":\"\"}], \"yield\":\"91.4%\"}, {\"meta\":{\"name\":\"Cap-Zn Coordination Polymer\", \"symbol\":\"\", \"chemical formula\":\"ZnC9H13NO3S\"}, \"processes\":[{\"synthesis method\":\"chemical synthesis\", \"precursor\":[{\"name\":\"captopril\", \"amount\":\"87\", \"unit\":\"mg\"}, {\"name\":\"ZnCl2\", \"amount\":\"136\", \"unit\":\"mg\"}, {\"name\":\"NaOH\", \"amount\":\"12\", \"unit\":\"mg\"}], \"solution\":[{\"name\":\"water\", \"amount\":\"2\", \"unit\":\"mL\"}, {\"name\":\"water\", \"amount\":\"3\", \"unit\":\"mL\"}], \"pressure\":\"\", \"temperature\":\"room temperature\", \"time\":\"overnight\"}, {\"synthesis method\":\"filtration\", \"time\":\"\", \"atmosphere\":\"\", \"pressure\":\"\"}, {\"synthesis method\":\"washing\", \"washing solution\":\"methanol\", \"amount\":\"\"}, {\"synthesis method\":\"drying\", \"pressure\":\"\", \"temperature\":\"\", \"atmosphere\":\"vacuum\", \"time\":\"\"}], \"yield\":\"90.3%\"}]\n```"}}, {"idx": 21, "type": "text", "classification": "property", "content": "<title>Stability</title><p>The thermal behaviors of <bold>Cap-Zn</bold> were\ninvestigated by DSC and TGA, and the results are presented\nin Figure . From the TG curve it can be found\nthat no weight loss belonging to residual solvent was detected. <bold>Cap-Zn</bold> can be stable up to 250 \u00b0C and then begins to\ndecompose upon further heating. Compared to the decomposition temperature\nof Cap at 170 \u00b0C, <bold>Cap-Zn</bold> shows the enhanced thermal\nstability (250 \u00b0C).</p>", "clean_text": "Stability\n\nThe thermal behaviors of Cap-Zn were investigated by DSC and TGA, and the results are presented in Figure . From the TG curve it can be found that no weight loss belonging to residual solvent was detected. Cap-Zn can be stable up to 250 \u00b0C and then begins to decompose upon further heating. Compared to the decomposition temperature of Cap at 170 \u00b0C, Cap-Zn shows the enhanced thermal stability (250 \u00b0C).", "data": [[[{"meta": {"name": "Cap-Zn", "symbol": "", "chemical formula": ""}, "decomposition temperature": [{"value": "250", "unit": "\u00b0C", "type": "decomposition point", "condition": "stable up to"}]}]]], "include_properties": ["decomposition_temperature"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['decomposition_temperature']", "text-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"Cap-Zn\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\"\n        },\n        \"decomposition temperature\": [\n            {\n                \"value\": \"250\",\n                \"unit\": \"\u00b0C\",\n                \"type\": \"decomposition point\",\n                \"condition\": \"stable up to\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 9, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystallographic Data and Refinements\nfor <bold>Cap-Zn</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup align=\"left\" cols=\"2\">\n<oasis:colspec colname=\"col1\"></oasis:colspec>\n<oasis:colspec colname=\"col2\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>Cap-Zn</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>formula</oasis:entry>\n<oasis:entry>ZnC<sub>9</sub>H<sub>13</sub>NO<sub>3</sub>S</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>formula weight</oasis:entry>\n<oasis:entry>280.63</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal system</oasis:entry>\n<oasis:entry>tetragonal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>4<sub>1</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.5790(12)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.5790(12)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>12.110(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (deg)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">V</italic> (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>1111.2(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">Z</italic>\n</oasis:entry>\n<oasis:entry>4</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">D</italic>\n<sub>c</sub> (g\u00b7cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.677</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">F</italic>(000)</oasis:entry>\n<oasis:entry>576</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal size (mm)</oasis:entry>\n<oasis:entry>0.08 \u00d7 0.05 \u00d7\n0.02</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>range of indices</oasis:entry>\n<oasis:entry>\u20138 \u2264 <italic toggle=\"yes\">h</italic> \u2264\n11</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\u201310 \u2264 <italic toggle=\"yes\">k</italic> \u2264\n9</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\u201314 \u2264 <italic toggle=\"yes\">l</italic> \u2264\n12</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>int</sub>\n</oasis:entry>\n<oasis:entry>0.0742</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF</oasis:entry>\n<oasis:entry>1.018</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub>[ <italic toggle=\"yes\">I</italic> &gt; 2\u03c3(<italic toggle=\"yes\">I</italic>)]<xref rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.0613</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub> [all\ndata]<xref rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.1589</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Flack parameter</oasis:entry>\n<oasis:entry>0.04(7)</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>\u03b1</label>\n<p>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = \u03a3\u2225F<sub>o</sub>| \u2013 |<italic toggle=\"yes\">F</italic>\n<sub>c</sub>\u2225/\u03a3|<italic toggle=\"yes\">F</italic>\n<sub>o</sub>|. <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = [\u03a3[<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2013 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/\u03a3<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup>)<sup>2</sup>]<sup>1/2</sup>, and <italic toggle=\"yes\">w</italic> = 1/[\u03c3<sup>2</sup>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>)<sup>2</sup> + (<italic toggle=\"yes\">aP</italic>)<sup>2</sup> + <italic toggle=\"yes\">bP</italic>], where <italic toggle=\"yes\">P</italic> = [(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup>) + 2<italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>]/3.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 1. Crystallographic Data and Refinements for Cap-Zn\n\n|                    | Cap-Zn           |\n|--------------------|------------------|\n| formula            | ZnC\u2089H\u2081\u2083NO\u2083S      |\n| formula weight     | 280.63           |\n| crystal system     | tetragonal       |\n| space group        | P4\u2081              |\n| a (\u00c5)               | 9.5790(12)       |\n| b (\u00c5)               | 9.5790(12)       |\n| c (\u00c5)               | 12.110(2)        |\n| \u03b1 (deg)             | 90               |\n| \u03b2 (deg)             | 90               |\n| \u03b3 (deg)             | 90               |\n| V (\u00c5\u00b3)              | 1111.2(3)        |\n| Z                   | 4                |\n| D\u2093 (g\u00b7cm\u207b\u00b3)         | 1.677            |\n| F(000)              | 576              |\n| crystal size (mm)  | 0.08 \u00d7 0.05 \u00d7 0.02 |\n| range of indices   | \u20138 \u2264 h \u2264 11      |\n|                    | \u201310 \u2264 k \u2264 9      |\n|                    | \u201314 \u2264 l \u2264 12     |\n| R\u1d62\u2099\u209c                | 0.0742           |\n| GOF                | 1.018            |\n| R\u2081[ I > 2\u03c3(I)][^\u03b1]  | 0.0613           |\n| wR\u2082 [all data][^\u03b1] | 0.1589           |\n| Flack parameter    | 0.04(7)          |\n\n[^\u03b1]: R\u2081 = \u03a3\u2225F\u2092| \u2013 |F\u1d62\u2225/\u03a3|F\u2092|. wR\u2082 = [\u03a3[w(F\u2092\u00b2 \u2013 F\u1d62\u00b2)\u00b2]/\u03a3w(F\u2092\u00b2)\u00b2]\u00b9/\u00b2, and w = 1/[\u03c3\u00b2(F\u2092)\u00b2 + (aP)\u00b2 + bP], where P = [(F\u2092\u00b2) + 2F\u1d62\u00b2]/3.", "data": [[{"meta": {"name": "Cap-Zn", "symbol": "", "chemical formula": "ZnC\u2089H\u2081\u2083NO\u2083S"}, "chemical formula weight": [{"value": "280.63", "unit": "", "condition": ""}], "crystal system": [{"value": "tetragonal", "condition": ""}], "space group": [{"value": "P4\u2081", "condition": ""}], "lattice parameters": [{"value": {"a": "9.5790(12)", "b": "9.5790(12)", "c": "12.110(2)", "alpha": "90", "beta": "90", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "1111.2(3)", "unit": "\u00c5\u00b3", "condition": ""}], "density": [{"value": "1.677", "unit": "g\u00b7cm\u207b\u00b3", "condition": ""}], "crystal size": [{"value": "0.08 \u00d7 0.05 \u00d7 0.02", "unit": "mm", "condition": ""}]}]], "include_properties": ["chemical_formula", "chemical_formula_weight", "crystal_system", "space_group", "lattice_parameters", "cell_volume", "density", "crystal_size"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. Crystallographic Data and Refinements for Cap-Zn\n\n|                    | Cap-Zn           |\n|--------------------|------------------|\n| formula            | ZnC\u2089H\u2081\u2083NO\u2083S      |\n| formula weight     | 280.63           |\n| crystal system     | tetragonal       |\n| space group        | P4\u2081              |\n| a (\u00c5)               | 9.5790(12)       |\n| b (\u00c5)               | 9.5790(12)       |\n| c (\u00c5)               | 12.110(2)        |\n| \u03b1 (deg)             | 90               |\n| \u03b2 (deg)             | 90               |\n| \u03b3 (deg)             | 90               |\n| V (\u00c5\u00b3)              | 1111.2(3)        |\n| Z                   | 4                |\n| D\u2093 (g\u00b7cm\u207b\u00b3)         | 1.677            |\n| F(000)              | 576              |\n| crystal size (mm)  | 0.08 \u00d7 0.05 \u00d7 0.02 |\n| range of indices   | \u20138 \u2264 h \u2264 11      |\n|                    | \u201310 \u2264 k \u2264 9      |\n|                    | \u201314 \u2264 l \u2264 12     |\n| R\u1d62\u2099\u209c                | 0.0742           |\n| GOF                | 1.018            |\n| R\u2081[ I > 2\u03c3(I)][^\u03b1]  | 0.0613           |\n| wR\u2082 [all data][^\u03b1] | 0.1589           |\n| Flack parameter    | 0.04(7)          |\n\n[^\u03b1]: R\u2081 = \u03a3\u2225F\u2092| \u2013 |F\u1d62\u2225/\u03a3|F\u2092|. wR\u2082 = [\u03a3[w(F\u2092\u00b2 \u2013 F\u1d62\u00b2)\u00b2]/\u03a3w(F\u2092\u00b2)\u00b2]\u00b9/\u00b2, and w = 1/[\u03c3\u00b2(F\u2092)\u00b2 + (aP)\u00b2 + bP], where P = [(F\u2092\u00b2) + 2F\u1d62\u00b2]/3.\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"Cap-Zn\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"ZnC\u2089H\u2081\u2083NO\u2083S\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"280.63\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"tetragonal\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P4\u2081\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"9.5790(12)\",\n                    \"b\": \"9.5790(12)\",\n                    \"c\": \"12.110(2)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"90\",\n                    \"gamma\": \"90\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1111.2(3)\",\n                \"unit\": \"\u00c5\u00b3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.677\",\n                \"unit\": \"g\u00b7cm\u207b\u00b3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.08 \u00d7 0.05 \u00d7 0.02\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 18, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Mean Pharmacokinetic\nParameters for\nCap and <bold>Cap-Zn</bold> in Male Rat (<italic toggle=\"yes\">n</italic> = 5)<xref rid=\"t2fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup align=\"left\" cols=\"3\">\n<oasis:colspec colname=\"col1\"></oasis:colspec>\n<oasis:colspec colname=\"col2\"></oasis:colspec>\n<oasis:colspec char=\" \u00b1 \" colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">parameter</oasis:entry>\n<oasis:entry align=\"center\">Cap</oasis:entry>\n<oasis:entry align=\"center\">Cap-Zn</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">t</italic>\n<sub>max</sub> (min)</oasis:entry>\n<oasis:entry>10</oasis:entry>\n<oasis:entry>23 \u00b1 2.74<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">C</italic>\n<sub>max</sub> (\u03bcg/mL)</oasis:entry>\n<oasis:entry>2.53 \u00b1 0.41</oasis:entry>\n<oasis:entry>0.99 \u00b1 0.15<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>AUC<sub>0\u2011\u221e</sub> (\u03bcg\u00b7min/mL)</oasis:entry>\n<oasis:entry>58.74 \u00b1 5.54</oasis:entry>\n<oasis:entry>42.03\n\u00b1 11.33<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>MRT<sub>0\u2011\u221e</sub> (min)</oasis:entry>\n<oasis:entry>31.56 \u00b1 6.10</oasis:entry>\n<oasis:entry>43.64\n\u00b1 5.73<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Each value represents the mean \u00b1\nSD (<italic toggle=\"yes\">n</italic> = 5).</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>\n<italic toggle=\"yes\">P</italic> &lt; 0.05.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 2. Mean Pharmacokinetic Parameters for Cap and Cap-Zn in Male Rat (n = 5)[^a]\n\n| parameter | Cap | Cap-Zn |\n|-----------|-----|--------|\n| t<sub>max</sub> (min) | 10 | 23 \u00b1 2.74[^b] |\n| C<sub>max</sub> (\u03bcg/mL) | 2.53 \u00b1 0.41 | 0.99 \u00b1 0.15[^b] |\n| AUC<sub>0\u2011\u221e</sub> (\u03bcg\u00b7min/mL) | 58.74 \u00b1 5.54 | 42.03 \u00b1 11.33[^b] |\n| MRT<sub>0\u2011\u221e</sub> (min) | 31.56 \u00b1 6.10 | 43.64 \u00b1 5.73[^b] |\n\n[^a]: Each value represents the mean \u00b1 SD (n = 5).\n[^b]: P < 0.05.", "data": [[{"meta": {"name": "Cap", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "tmax", "value": "10", "unit": "min", "condition": "mean (n = 5)"}, {"property name": "Cmax", "value": "2.53 \u00b1 0.41", "unit": "\u03bcg/mL", "condition": "mean \u00b1 SD (n = 5)"}, {"property name": "AUC0\u2011\u221e", "value": "58.74 \u00b1 5.54", "unit": "\u03bcg\u00b7min/mL", "condition": "mean \u00b1 SD (n = 5)"}, {"property name": "MRT0\u2011\u221e", "value": "31.56 \u00b1 6.10", "unit": "min", "condition": "mean \u00b1 SD (n = 5)"}]}, {"meta": {"name": "Cap-Zn", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "tmax", "value": "23 \u00b1 2.74", "unit": "min", "condition": "mean \u00b1 SD (n = 5), P < 0.05"}, {"property name": "Cmax", "value": "0.99 \u00b1 0.15", "unit": "\u03bcg/mL", "condition": "mean \u00b1 SD (n = 5), P < 0.05"}, {"property name": "AUC0\u2011\u221e", "value": "42.03 \u00b1 11.33", "unit": "\u03bcg\u00b7min/mL", "condition": "mean \u00b1 SD (n = 5), P < 0.05"}, {"property name": "MRT0\u2011\u221e", "value": "43.64 \u00b1 5.73", "unit": "min", "condition": "mean \u00b1 SD (n = 5), P < 0.05"}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 2. Mean Pharmacokinetic Parameters for Cap and Cap-Zn in Male Rat (n = 5)[^a]\n\n| parameter | Cap | Cap-Zn |\n|-----------|-----|--------|\n| t<sub>max</sub> (min) | 10 | 23 \u00b1 2.74[^b] |\n| C<sub>max</sub> (\u03bcg/mL) | 2.53 \u00b1 0.41 | 0.99 \u00b1 0.15[^b] |\n| AUC<sub>0\u2011\u221e</sub> (\u03bcg\u00b7min/mL) | 58.74 \u00b1 5.54 | 42.03 \u00b1 11.33[^b] |\n| MRT<sub>0\u2011\u221e</sub> (min) | 31.56 \u00b1 6.10 | 43.64 \u00b1 5.73[^b] |\n\n[^a]: Each value represents the mean \u00b1 SD (n = 5).\n[^b]: P < 0.05.\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"Cap\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"tmax\",\n                \"value\": \"10\",\n                \"unit\": \"min\",\n                \"condition\": \"mean (n = 5)\",\n            },\n            {\n                \"property name\": \"Cmax\",\n                \"value\": \"2.53 \u00b1 0.41\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"mean \u00b1 SD (n = 5)\",\n            },\n            {\n                \"property name\": \"AUC0\u2011\u221e\",\n                \"value\": \"58.74 \u00b1 5.54\",\n                \"unit\": \"\u03bcg\u00b7min/mL\",\n                \"condition\": \"mean \u00b1 SD (n = 5)\",\n            },\n            {\n                \"property name\": \"MRT0\u2011\u221e\",\n                \"value\": \"31.56 \u00b1 6.10\",\n                \"unit\": \"min\",\n                \"condition\": \"mean \u00b1 SD (n = 5)\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"Cap-Zn\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"tmax\",\n                \"value\": \"23 \u00b1 2.74\",\n                \"unit\": \"min\",\n                \"condition\": \"mean \u00b1 SD (n = 5), P < 0.05\",\n            },\n            {\n                \"property name\": \"Cmax\",\n                \"value\": \"0.99 \u00b1 0.15\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"mean \u00b1 SD (n = 5), P < 0.05\",\n            },\n            {\n                \"property name\": \"AUC0\u2011\u221e\",\n                \"value\": \"42.03 \u00b1 11.33\",\n                \"unit\": \"\u03bcg\u00b7min/mL\",\n                \"condition\": \"mean \u00b1 SD (n = 5), P < 0.05\",\n            },\n            {\n                \"property name\": \"MRT0\u2011\u221e\",\n                \"value\": \"43.64 \u00b1 5.73\",\n                \"unit\": \"min\",\n                \"condition\": \"mean \u00b1 SD (n = 5), P < 0.05\",\n            }\n        ],\n    }\n]\n```"}}, {"idx": 3, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Structure of Captopril\n(Cap) and Captopril Disulfide (Di-Cap)</title>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0008.tif\"></graphic>\n</fig>", "clean_text": " 1  Structure of Captopril (Cap) and Captopril Disulfide (Di-Cap)   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 20, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>(a) Coordination environments of Zn and coordination\nmode of Cap.\n(b) Side view of 1D right-handed helical chain along the <italic toggle=\"yes\">c</italic> axis. (c) Coordination bonds between the adjacent helical chains.\n(d) Three-dimensional structure of <bold>Cap-Zn</bold> (view from\nthe <italic toggle=\"yes\">c</italic> axis).</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0002.tif\"></graphic>\n</fig>", "clean_text": " 1  (a) Coordination environments of Zn and coordination mode of Cap. (b) Side view of 1D right-handed helical chain along the c axis. (c) Coordination bonds between the adjacent helical chains. (d) Three-dimensional structure of Cap-Zn (view from the c axis).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>DSC and TG curves for <bold>Cap-Zn</bold> (red)\nand Cap (blue).</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0003.tif\"></graphic>\n</fig>", "clean_text": " 2  DSC and TG curves for Cap-Zn (red) and Cap (blue).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Powder dissolution profiles for Cap and <bold>Cap-Zn</bold> in\nTris-HCl buffer of pH 6.8 (a) and 0.1 M HCl aqueous solution (b).</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0004.tif\"></graphic>\n</fig>", "clean_text": " 3  Powder dissolution profiles for Cap and Cap-Zn in Tris-HCl buffer of pH 6.8 (a) and 0.1 M HCl aqueous solution (b).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>XRPD patterns for <bold>Cap-Zn</bold> after\npowder dissolution\nexperiment in Tris-HCl buffer of pH 6.8 (blue) and 0.1 M HCl aqueous\nsolution (red) (black, simulated XRPD pattern from the single-crystal\ndiffraction of <bold>Cap-Zn</bold>).</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0005.tif\"></graphic>\n</fig>", "clean_text": " 4  XRPD patterns for Cap-Zn after powder dissolution experiment in Tris-HCl buffer of pH 6.8 (blue) and 0.1 M HCl aqueous solution (red) (black, simulated XRPD pattern from the single-crystal diffraction of Cap-Zn).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 29, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>IDR profiles for Cap\nand <bold>Cap-Zn</bold> in 0.1 M HCl aqueous\nsolution.</p>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0006.tif\"></graphic>\n</fig>", "clean_text": " 5  IDR profiles for Cap and Cap-Zn in 0.1 M HCl aqueous solution.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 31, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Plasma\nconcentration\u2013time profiles for Cap and <bold>Cap-Zn</bold> after oral administration. Each point represents the mean \u00b1\nSD (<italic toggle=\"yes\">n</italic> = 5).</p>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"float\" xlink:href=\"cg-2014-00302h_0007.tif\"></graphic>\n</fig>", "clean_text": " 6  Plasma concentration-time profiles for Cap and Cap-Zn after oral administration. Each point represents the mean \u00b1 SD (n = 5).   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/cg500302h", "title": "\nNew Approach to Reduce the Overhigh Plasma Concentration\nof Captopril by the Formation of Zinc Coordination Polymer\n", "journal": "American Chemical\nSociety", "date": "2014.04", "author_list": ["Yao\nJia", "Mo\nYong-Hui", "Chen\nJia-Mei", "Lu\nTong-Bu"]}}